BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10800180)

  • 1. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
    Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
    Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
    Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
    Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic myeloproliferative diseases. Clinical and cytogenetic study].
    Fernández Rodríguez MN
    Sangre (Barc); 1971; 16(2):159-84. PubMed ID: 5282697
    [No Abstract]   [Full Text] [Related]  

  • 4. [A cytogenetical study of chronic myeloid leukemia, osteomyelosclerosis, myelofibrosis and erythrema].
    Piatkin EK
    Tsitologiia; 1966; 8(2):229-40. PubMed ID: 5234136
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloid metaplasia: clinical, laboratory and cytogenetic observations.
    Better O; Brandstaetter S; Padeh B; Bianu G
    Isr J Med Sci; 1965 Jul; 1(4):810-7. PubMed ID: 5216388
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chromosome complexes in patients with leukemia, erythremia, and myelofibrosis].
    Zakharova AV; Korenevskaia MI; Mokeeva RA; Klimova NF; Kovaleva LG
    Probl Gematol Pereliv Krovi; 1971 May; 16(5):3-8. PubMed ID: 5292232
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromosome abnormalities in human leukemia.
    Sandberg AA
    Geriatrics; 1968 May; 23(5):124-36. PubMed ID: 5239067
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel cytogenetic abnormality in primary myelofibrosis.
    Bae SY; Kim JS; Lee KN; Lee CK; Kim YK; Yoon SY; Lim CS; Cho YJ; Choi CW; Kim WY
    Cancer Genet Cytogenet; 2009 Oct; 194(1):65-6. PubMed ID: 19737657
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A; Loo H; Prost RJ; Doumenc J; Zittoun R; Bilski-Pasquier G
    Sem Hop; 1968 Jun; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
    Tefferi A; Dingli D; Li CY; Dewald GW
    Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
    Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
    Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.
    Lazarevic V; Andersson C; Wahlin A; Golovleva I
    Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential thrombocythemia with myelofibrosis transformed into acute myeloid leukemia with der(1;15)(q10;q10): case report and literature review.
    Charafeddine KM; Mahfouz RA; Zaatari GS; Ibrahim GY; Muwakkit SA; Najm ND; Farra CG
    Cancer Genet Cytogenet; 2010 Jul; 200(1):28-33. PubMed ID: 20513531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia with myelofibrosis. Four years after auto-immune hemolytic anemia.
    Cohen SM
    Arch Intern Med; 1967 Jun; 119(6):620-5. PubMed ID: 5229776
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosomal abnormalities in human neoplasia.
    Sandberg AA; Hossfeld DK
    Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449
    [No Abstract]   [Full Text] [Related]  

  • 16. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
    Toubai T; Tanaka J; Higa T; Ota S; Ibata M; Shono Y; Mashiko S; Miura Y; Umehara S; Kahata K; Toyoshima N; Morioka M; Asaka M; Kasai M; Imamura M
    Am J Hematol; 2005 Jan; 78(1):67-70. PubMed ID: 15609290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosome abnormalities in hematological diseases].
    Jensen MK
    Ugeskr Laeger; 1976 Mar; 138(11):657-60. PubMed ID: 1062867
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical cytogenetics. IV. Chromosomes in malignancies.
    Krompotic E; Zellner JM
    Chic Med Sch Q; 1968; 27(4):171-85. PubMed ID: 5269359
    [No Abstract]   [Full Text] [Related]  

  • 20. Karyotype evolution of cells with the Philadelphia chromosome.
    Meisner L; Inhorn SL; Nielsen P
    Acta Cytol; 1970 Apr; 14(4):192-9. PubMed ID: 5266594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.